Skip to main content
. 2012 Sep;80(3):398–405. doi: 10.1111/j.1747-0285.2012.01416.x

Figure 1.

Figure 1

 The structures of all experimentally validated compounds. Associated IC50 values are given for the top three non-aggregating inhibitors. Means and standard deviations were calculated by considering all IC50 values associated with each compound, measured under varying experimental conditions as described in the Experimental Methods (n = 8). *NSC 61610 appears to inhibit cruzain nonspecifically via aggregation (see the Supporting Information).